Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Histological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05363800
What this trial is testing

Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma

Who this might be right for
Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma
Jiangsu HengRui Medicine Co., Ltd. 74
Testing effectiveness (Phase 2)Looking for participantsNCT07126236
What this trial is testing

Response-adaptive to Epcoritamab In First Relapse: Study to Evaluate the Efficacy of Eptoritamab in Patients With Relapse/Refractory Large B Cell Lymphoma

Who this might be right for
Large B Cell Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 80
Testing effectiveness (Phase 2)Study completedNCT01417936
What this trial is testing

Sym004 in SCCHN Patients Failing Anti-EGFR Based Therapy

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
Symphogen A/S 26
Not applicableStudy completedNCT03955900
What this trial is testing

A Registry Study of Participants With Multiple Myeloma in Latin America

Who this might be right for
Multiple Myeloma
Janssen-Cilag Ltd. 2,059
Not applicableUnknownNCT04070807
What this trial is testing

Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhibiting BCL-2

Who this might be right for
Acute Myeloid Leukemia
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 70
Testing effectiveness (Phase 2)Study completedNCT00004907
What this trial is testing

Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University
Early research (Phase 1)Ended earlyNCT01034592
What this trial is testing

Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia

Who this might be right for
AnemiaLeukemiaAcute Myeloid Leukemia (AML)+1 more
Jason Robert Gotlib 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT05768711
What this trial is testing

Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR)

Who this might be right for
Chronic Myeloid Leukemia
Groupe Francophone des Myelodysplasies 44
Not applicableStudy completedNCT02100371
What this trial is testing

Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome

Who this might be right for
Basal Cell Nevus Syndrome
University Health Network, Toronto 2
Testing effectiveness (Phase 2)Study completedNCT03034200
What this trial is testing

Phase 2 Study of ONC201 in Neuroendocrine Tumors

Who this might be right for
Recurrent Neuroendocrine TumorMetastatic Neuroendocrine Tumor
Peter Anderson 30
Not applicableNot Yet RecruitingNCT07029100
What this trial is testing

Feasibility of ORGAnoids in Routine Clinical Practice for Molecular Analysis of the GLIOvascular Niche in Patients With Primary Brain Tumors.

Who this might be right for
Glioblastoma
Centre Henri Becquerel 30
Testing effectiveness (Phase 2)Study completedNCT01610336
What this trial is testing

A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment

Who this might be right for
Non-small Cell Lung Cancer
Novartis Pharmaceuticals 161
Not applicableStudy completedNCT00877136
What this trial is testing

A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®

Who this might be right for
Liver TumorsHepatocellular CarcinomaHepatoma+1 more
St. Joseph Hospital of Orange 18
Testing effectiveness (Phase 2)WithdrawnNCT01600807
What this trial is testing

OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer, Metastatic
Dana-Farber Cancer Institute
Not applicableLooking for participantsNCT07570407
What this trial is testing

Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation

Who this might be right for
Allogeneic HSCTPosttransplant ComplicationsGvHD+2 more
University Hospital Pilsen 75
Testing effectiveness (Phase 2)Study completedNCT00563836
What this trial is testing

Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer

Who this might be right for
Ovarian CancerEpithelial Ovarian Cancer
Neovii Biotech 41
Early research (Phase 1)Active Not RecruitingNCT03240211
What this trial is testing

Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL

Who this might be right for
PTCLCTCL
University of Virginia 37
Testing effectiveness (Phase 2)Study completedNCT02301611
What this trial is testing

Phase IIB TL + YCWP + DC in Melanoma

Who this might be right for
Melanoma
Elios Therapeutics, LLC 187
Not applicableStudy completedNCT00716911
What this trial is testing

Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 100
Early research (Phase 1)Not Yet RecruitingNCT06500507
What this trial is testing

QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Qilu Pharmaceutical Co., Ltd. 90
Next Page